Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal

29Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The abnormal accumulation of methylglyoxal (MG), a physiological glucose metabolite, is strongly related to the development of diabetic complications by affecting the metabolism and functions of organs and tissues. These disturbances could modify the cell response to hormones and growth factors, including insulin-like growth factor-1 (IGF-I). In this study, we investigated the effect of MG on IGF-I-induced cell proliferation and the mechanism of the effect in two cell lines, a human embryonic kidney cell line (HEK293), and a mouse fibroblast cell line (NIH3T3). MG rendered these cells resistant to the mitogenic action of IGF-I, and this was associated with stronger and prolonged activation of ERK and over-expression of P21Waf1/Cip1. The synergistic effect of MG with IGF-I in activation of ERK was completely abolished by PD98059 but not by a specific PI3K inhibitor, LY294002, or a specific PKC inhibitor, bisindolylmaleimide. Blocking of Raf-1 activity by expression of a dominant negative form of Raf-1 did not reduce the enhancing effect of MG on IGF-I-induced activation of ERK. However, transfection of a catalytically inactive form of MEKK1 resulted in inactivation of the MG-induced activation of ERK and partial inhibition of the enhanced activation of ERK and over-expression of p21Waf1/Cip1 induced by co-stimulation of MG and IGF-I. These results suggested that the alteration of intracellular milieu induced by MG through a MEKK1-mediated and PI3K/PKC/Raf-1-independent pathway resulted in the modification of cell response to IGF-I for p21Waf1/Cip1-mediated growth arrest, which may be one of the crucial mechanisms for MG to promote the development of chronic clinical complications in diabetes. © 2003 Wiley-Liss, Inc.

References Powered by Scopus

The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus

0
23931Citations
N/AReaders
Get full text

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

18931Citations
N/AReaders
Get full text

Biochemistry and molecular cell biology of diabetic complications

7630Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Injectable, rapid gelling and highly flexible hydrogel composites as growth factor and cell carriers

183Citations
N/AReaders
Get full text

Methylglyoxal, obesity, and diabetes

141Citations
N/AReaders
Get full text

Glyoxalase and Methylglyoxal as Biomarkers for Plant Stress Tolerance

132Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Du, J., Cai, S., Suzuki, H., Akhand, A. A., Ma, X., Takagi, Y., … Nagase, F. (2003). Involvement of MEKK1/ERK/P21Waf1/Cip1 signal transduction pathway in inhibition of IGF-I-mediated cell growth response by methylglyoxal. Journal of Cellular Biochemistry, 88(6), 1235–1246. https://doi.org/10.1002/jcb.10478

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 6

46%

Researcher 4

31%

Professor / Associate Prof. 3

23%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 4

40%

Biochemistry, Genetics and Molecular Bi... 3

30%

Pharmacology, Toxicology and Pharmaceut... 2

20%

Neuroscience 1

10%

Save time finding and organizing research with Mendeley

Sign up for free